Fluid management in critically ill pediatric patients with congenital heart disease

Z Ricci1, C Iacoella, P Cogo

  • 1Department of Pediatric Cardiac Surgery, Bambino Gesù Children's Hospital, Rome, Italy. z.ricci@libero.it

Minerva Pediatrica
|September 28, 2011
PubMed

Insights

Managing fluid overload in critically ill children with congenital heart disease is crucial. This review examines diuretic therapies and fluid removal strategies to improve outcomes in pediatric intensive care units.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pediatric Cardiology
  • Nephrology

Background:

  • Fluid overload (FO) is a significant trigger of multiple organ dysfunction in pediatric intensive care units (ICUs).
  • Pediatric patients with congenital heart disease (CHD) face elevated risks of fluid management issues due to pre, intra, and postoperative factors.
  • Infants with acute kidney injury and CHD are particularly vulnerable to severe edema, capillary leak syndrome, and FO, often associated with poor outcomes.

Purpose of the Study:

  • To review current literature on fluid balance management in critically ill children with CHD.
  • To discuss the efficacy, dosages, benefits, and drawbacks of diuretic therapies.
  • To explore alternative diuretic and nephroprotective drugs and extracorporeal fluid removal techniques in pediatric cardiac surgery.

Main Methods:

  • Comprehensive literature review of recent studies on fluid balance in pediatric critical care.
  • Analysis of diuretic therapy, including dosages and clinical applications.
  • Examination of emerging nephroprotective agents and extracorporeal fluid removal modalities.

Main Results:

  • Children with severe renal dysfunction requiring renal replacement therapy (RRT) exhibit a higher incidence of FO, linked to adverse outcomes.
  • Correction of water overload is a priority in pediatric fluid management.
  • The review synthesizes data on various therapeutic interventions and monitoring strategies.

Conclusions:

  • Effective fluid balance management is critical for improving outcomes in pediatric critically ill patients with CHD.
  • Diuretic therapy and advanced fluid removal techniques are essential components of care.
  • Further research into novel nephroprotective strategies is warranted for this vulnerable population.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...